The global market for Continuous Glucose Monitoring (CGM) Systems for Diabetics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring (CGM) Systems for Diabetics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Continuous Glucose Monitoring (CGM) Systems for Diabetics by region & country, by Type, and by Application.
The Continuous Glucose Monitoring (CGM) Systems for Diabetics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring (CGM) Systems for Diabetics.
Market Segmentation
By Company
Abbott Diabetes Care Inc.
Dexcom
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
Segment by Type:
Wearable
Implantable
Segment by Application
Hospitals & Clinics
Homecare Settings
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Continuous Glucose Monitoring (CGM) Systems for Diabetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Continuous Glucose Monitoring (CGM) Systems for Diabetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Continuous Glucose Monitoring (CGM) Systems for Diabetics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Introduction
1.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size Forecast
1.2.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value (2019-2030)
1.2.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume (2019-2030)
1.2.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Price (2019-2030)
1.3 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Trends & Drivers
1.3.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Industry Trends
1.3.2 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Drivers & Opportunity
1.3.3 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Challenges
1.3.4 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Players Revenue Ranking (2023)
2.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Company (2019-2024)
2.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Players Sales Volume Ranking (2023)
2.4 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume by Company Players (2019-2024)
2.5 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Average Price by Company (2019-2024)
2.6 Key Manufacturers Continuous Glucose Monitoring (CGM) Systems for Diabetics Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Continuous Glucose Monitoring (CGM) Systems for Diabetics
2.9 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Competitive Analysis
2.9.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Glucose Monitoring (CGM) Systems for Diabetics as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Wearable
3.1.2 Implantable
3.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Type
3.2.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, by Type (2019-2030)
3.2.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, by Type (%) (2019-2030)
3.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume by Type
3.3.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume, by Type (2019-2030)
3.3.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume, by Type (%) (2019-2030)
3.4 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals & Clinics
4.1.2 Homecare Settings
4.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Application
4.2.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, by Application (2019-2030)
4.2.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, by Application (%) (2019-2030)
4.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume by Application
4.3.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume, by Application (2019-2030)
4.3.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume, by Application (%) (2019-2030)
4.4 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Region
5.1.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Region (2019-2024)
5.1.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Region (2025-2030)
5.1.4 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Region (%), (2019-2030)
5.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume by Region
5.2.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume by Region (2019-2024)
5.2.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume by Region (2025-2030)
5.2.4 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume by Region (%), (2019-2030)
5.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, 2019-2030
5.4.2 North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, 2019-2030
5.5.2 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, 2019-2030
5.6.2 Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, 2019-2030
5.7.2 South America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, 2019-2030
5.8.2 Middle East & Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value
6.2.1 Key Countries/Regions Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, 2019-2030
6.2.2 Key Countries/Regions Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, 2019-2030
6.3.2 United States Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, 2019-2030
6.4.2 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, 2019-2030
6.5.2 China Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, 2019-2030
6.6.2 Japan Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, 2019-2030
6.7.2 South Korea Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, 2019-2030
6.8.2 Southeast Asia Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value, 2019-2030
6.9.2 India Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Diabetes Care Inc.
7.1.1 Abbott Diabetes Care Inc. Company Information
7.1.2 Abbott Diabetes Care Inc. Introduction and Business Overview
7.1.3 Abbott Diabetes Care Inc. Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Abbott Diabetes Care Inc. Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Offerings
7.1.5 Abbott Diabetes Care Inc. Recent Development
7.2 Dexcom
7.2.1 Dexcom Company Information
7.2.2 Dexcom Introduction and Business Overview
7.2.3 Dexcom Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Dexcom Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Offerings
7.2.5 Dexcom Recent Development
7.3 Medtronic
7.3.1 Medtronic Company Information
7.3.2 Medtronic Introduction and Business Overview
7.3.3 Medtronic Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Medtronic Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Offerings
7.3.5 Medtronic Recent Development
7.4 Senseonics Holdings
7.4.1 Senseonics Holdings Company Information
7.4.2 Senseonics Holdings Introduction and Business Overview
7.4.3 Senseonics Holdings Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Senseonics Holdings Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Offerings
7.4.5 Senseonics Holdings Recent Development
7.5 GlySens Incorporated
7.5.1 GlySens Incorporated Company Information
7.5.2 GlySens Incorporated Introduction and Business Overview
7.5.3 GlySens Incorporated Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2019-2024)
7.5.4 GlySens Incorporated Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Offerings
7.5.5 GlySens Incorporated Recent Development
7.6 Meiqi Medical Equipment
7.6.1 Meiqi Medical Equipment Company Information
7.6.2 Meiqi Medical Equipment Introduction and Business Overview
7.6.3 Meiqi Medical Equipment Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Meiqi Medical Equipment Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Offerings
7.6.5 Meiqi Medical Equipment Recent Development
7.7 San Meditech
7.7.1 San Meditech Company Information
7.7.2 San Meditech Introduction and Business Overview
7.7.3 San Meditech Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2019-2024)
7.7.4 San Meditech Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Offerings
7.7.5 San Meditech Recent Development
8 Industry Chain Analysis
8.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Industrial Chain
8.2 Continuous Glucose Monitoring (CGM) Systems for Diabetics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Model
8.5.2 Sales Channel
8.5.3 Continuous Glucose Monitoring (CGM) Systems for Diabetics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Abbott Diabetes Care Inc.
Dexcom
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
听
听
*If Applicable.
